Tuck, Alan B <br/><br/>
Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.  [electronic resource] 

 -  Oncogene  Feb 2003 
 - 1198-205 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1206209  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Breast--cytology<br/>Breast Neoplasms--pathology<br/>Cell Movement--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Epidermal Growth Factor--biosynthesis<br/>Epithelial Cells--drug effects<br/>ErbB Receptors--biosynthesis<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Oligonucleotides, Antisense--pharmacology<br/>Osteopontin<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase C--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-met--drug effects<br/>RNA, Messenger--biosynthesis<br/>Recombinant Fusion Proteins--physiology<br/>Recombinant Proteins--pharmacology<br/>Sialoglycoproteins--pharmacology<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor alpha--antagonists & inhibitors<br/>Tumor Cells, Cultured--cytology<br/>Type C Phospholipases--antagonists & inhibitors